248 related articles for article (PubMed ID: 10643625)
1. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis.
Pinzani M; Gentilini P
Semin Liver Dis; 1999; 19(4):397-410. PubMed ID: 10643625
[TBL] [Abstract][Full Text] [Related]
2. Liver fibrosis: from the bench to clinical targets.
Pinzani M; Rombouts K
Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
[TBL] [Abstract][Full Text] [Related]
3. Role of hepatic stellate cells in the pathogenesis of portal hypertension.
Marra F; Pinzani M
Nefrologia; 2002; 22 Suppl 5():34-40. PubMed ID: 12107915
[No Abstract] [Full Text] [Related]
4. Hepatic fibrosis, stellate cells, and portal hypertension.
Rockey DC
Clin Liver Dis; 2006 Aug; 10(3):459-79, vii-viii. PubMed ID: 17162223
[TBL] [Abstract][Full Text] [Related]
5. Hepatic blood flow regulation by stellate cells in normal and injured liver.
Rockey DC
Semin Liver Dis; 2001 Aug; 21(3):337-49. PubMed ID: 11586464
[TBL] [Abstract][Full Text] [Related]
6. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide.
Rockey D
Hepatology; 1997 Jan; 25(1):2-5. PubMed ID: 8985256
[No Abstract] [Full Text] [Related]
7. Cirrhosis--can we reverse hepatic fibrosis?
Tangkijvanich P; Yee HF
Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis.
Siegmund SV; Schwabe RF
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G357-62. PubMed ID: 18006606
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
Gatta A; Bolognesi M; Merkel C
Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
[TBL] [Abstract][Full Text] [Related]
10. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
Svegliati-Baroni G; De Minicis S; Marzioni M
Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548
[TBL] [Abstract][Full Text] [Related]
11. New concepts in the pathogenesis of portal hypertension: hepatic wounding and stellate cell contractility.
Rockey DC
Clin Liver Dis; 1997 May; 1(1):13-29. PubMed ID: 15562665
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
Wiest R; Groszmann RJ
Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
[TBL] [Abstract][Full Text] [Related]
13. Regulation of sinusoidal perfusion in portal hypertension.
Reynaert H; Urbain D; Geerts A
Anat Rec (Hoboken); 2008 Jun; 291(6):693-8. PubMed ID: 18484616
[TBL] [Abstract][Full Text] [Related]
14. Liver cirrhosis.
Pinzani M; Rosselli M; Zuckermann M
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):281-90. PubMed ID: 21497745
[TBL] [Abstract][Full Text] [Related]
15. Liver fibrosis.
Pinzani M
Springer Semin Immunopathol; 1999; 21(4):475-90. PubMed ID: 10945037
[TBL] [Abstract][Full Text] [Related]
16. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis.
Moreno-Merlo F; Wanless IR; Shimamatsu K; Sherman M; Greig P; Chiasson D
Hepatology; 1997 Sep; 26(3):554-60. PubMed ID: 9303482
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of extrahepatic vasodilation in portal hypertension.
Hennenberg M; Trebicka J; Sauerbruch T; Heller J
Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
[TBL] [Abstract][Full Text] [Related]
18. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
[TBL] [Abstract][Full Text] [Related]
19. Vascular deterioration in cirrhosis: the big picture.
Bosch J
J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
[TBL] [Abstract][Full Text] [Related]
20. [Nitric oxide, vasodilatation and cirrhosis: a double (dys)equilibrium].
Sogni P; Moreau R; Lebrec D
Gastroenterol Clin Biol; 1999 Jan; 23(1):101-4. PubMed ID: 10219610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
